Short description
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications.
Description
Kite Pharma is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient's own immune system to fight tumor cells. These potential therapies could provide novel strategies for the treatment and management of a wide range of tumor types.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Los Angeles, California, United States, North America
Founded on
January 1, 2009
Exited on
June 27, 2014
Went public on
June 27, 2014
Delisted on
October 3, 2017
Stock symbol
KITE
Non-profit?
No
Acquired?
No
Employees count
1001-5000
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noway Youcantaccess, Noaccessforu, Uh Ohhhh, No Way, Noaccess
Sign in for full access
Founders
Arie Belldegrun, Joshua Kazam
Funding rounds count
12
Portfolio organisations count
Noaccessforu, Blurry Noaccess
Sign in for full access
Lead investments count
2
Exits count
Blurry Noaccess, Noaccess
Sign in for full access
IPO exits count
4